Outcome in prenatally diagnosed fetal agenesis of the corpus callosum

被引:71
|
作者
Goodyear, PWA [1 ]
Bannister, CM [1 ]
Russell, S [1 ]
Rimmer, S [1 ]
机构
[1] Univ Manchester, St Marys Hosp, Fetal Mangement Unit, Manchester M13 0JH, Lancs, England
关键词
agenesis of the corpus callosum; prenatal diagnosis; prenatal counselling; associated anomalies; chromosomal abnormalities;
D O I
10.1159/000053898
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
This study of the outcome and prognostic factors in prenatally diagnosed agenesis of the corpus callosum (ACC) was undertaken to see if there are any differences between subgroups, what relationship they have to neurodevelopmental outcome and whether this information aids the counselling of parents of fetuses with the condition. The outcome of 14 prenatally diagnosed fetuses with ACC and 61 postnatally diagnosed patients was assessed in terms of clinical problems, developmental milestones and neurological signs; each patient was then given a score out of 10, 0 being a normal outcome and 10 being the worst outcome, i,e, death or termination of pregnancy. Comparing patients diagnosed pre-and postnatally, several similarities were found indicating that the postnatal group can provide useful information about the prenatal group. There was a higher incidence of ACC in males than females. In the prenatally diagnosed patients complete ACC was more common than partial ACC, although this might be because partial ACC was easily missed. Complete ACC has a worse prognosis than partial ACC (p = 0.001), and when associated with other anomalies, especially of the central nervous system, the outcome is very bad (p < 0.01). The only neurodevelopmentally normal patients were in the isolated partial ACC group. This study highlights the need to perform a detailed review of fetal anatomy and the desirability of determining the karyotype of the fetus in all newly diagnosed cases of ACC so that as much information as possible is available before parents are counselled about the likely outcome. Copyright (C) 2001 S. Karger AG. Basel.
引用
收藏
页码:139 / 145
页数:7
相关论文
共 50 条
  • [31] Corpus callosum agenesis
    Chacko, A
    Koul, R
    Sankhla, DK
    SAUDI MEDICAL JOURNAL, 2001, 22 (01) : 22 - 25
  • [32] Agenesis of the corpus callosum
    Singh, Sangram
    Garge, Saurabh
    JOURNAL OF PEDIATRIC NEUROSCIENCES, 2010, 5 (01) : 83 - +
  • [33] AGENESIS OF CORPUS CALLOSUM
    LOESER, JD
    ALVORD, EC
    BRAIN, 1968, 91 : 553 - &
  • [34] Agenesis of the Corpus Callosum
    Mitrache, Dana
    Pantea, Manuela
    Angelescu-Coptil, Claudiu
    El Ghazi, Ghita
    PROCEEDINGS OF THE 6TH CONGRESS OF THE ULTRASOUND SOCIETY IN OBSTETRICS AND GYNECOLOGY / 34TH FETUS AS A PATIENT INTERNATIONAL CONGRESS, 2018, : 301 - 305
  • [35] Corpus callosum agenesis
    Gonçlves-Ferreira, T
    Sousa-Guarda, C
    Oliver-Monteiro, JP
    Carmo-Fonseca, MJ
    Filipe-Saraiva, P
    Goulao-Constâncio, A
    REVISTA DE NEUROLOGIA, 2003, 36 (08) : 701 - 706
  • [36] AGENESIS OF THE CORPUS CALLOSUM
    Lloyd, J. S.
    Jacobson, J. N.
    JOURNAL OF MENTAL SCIENCE, 1938, 84 (353): : 995 - 998
  • [37] Analysis of the Anatomical Variability of Fetal Brains with Corpus Callosum Agenesis
    Gaudfernau, Fleur
    Blondiaux, Eleonore
    Allassoniere, Stephanie
    UNCERTAINTY FOR SAFE UTILIZATION OF MACHINE LEARNING IN MEDICAL IMAGING, AND PERINATAL IMAGING, PLACENTAL AND PRETERM IMAGE ANALYSIS, 2021, 12959 : 274 - 283
  • [38] Beyond fetal magnetic resonance diagnosis of corpus callosum agenesis
    Rania S. M. Ibrahim
    S. Emad-Eldin
    Egyptian Journal of Radiology and Nuclear Medicine, 51
  • [39] Disorganized Sulcal Pattern in Fetal Brains with Agenesis of Corpus Callosum
    Tarui, T.
    Mada, N.
    Farhat, N.
    Kitano, R.
    Tanritanir, A.
    Graham, G.
    Rollins, C.
    Ortinau, C.
    Bianchi, D.
    Grant, E.
    Im, K.
    ANNALS OF NEUROLOGY, 2016, 80 : S358 - S358
  • [40] Beyond fetal magnetic resonance diagnosis of corpus callosum agenesis
    Ibrahim, Rania S. M.
    Emad-Eldin, Sally
    EGYPTIAN JOURNAL OF RADIOLOGY AND NUCLEAR MEDICINE, 2020, 51 (01):